Skip to content

Replimune Group REPL Income Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$53.14M+10.7%$57.88M+33.2%$57.84M+34.6%$53.98M+26.8%$48M+12.0%
$18.73M+4.0%$26.41M+70.8%$32.58M+126%$25.35M+56.7%$18.02M+31.6%
$71.87M+8.9%$84.29M+43.1%$90.42M+57.6%$79.33M+35.0%$66.02M+16.8%
$71.87M+8.9%$84.29M+43.1%$90.42M+57.6%$79.33M+35.0%$66.02M+16.8%
-$71.87M-8.9%-$84.29M-43.1%-$90.42M-57.6%-$79.33M-35.0%-$66.02M-16.8%
$1.47M+1.1%$1.49M+3.5%$1.48M+3.4%$1.46M+3.3%$1.45M+43.3%
$2.85M-44.6%$3.7M-31.5%$4.71M+0.1%$5.88M+8.2%$5.14M-9.7%
$627K+147%$1.19M-79.7%$3.73M+3.7%$5.09M+40.8%$254K-95.7%
-$71.24M-8.3%-$74.24M-34.6%-$65.77M-29.8%
-$311K-154%$575K+21.6%
-$70.93M-6.9%-$83.1M-56.6%-$86.69M-61.2%-$74.13M-34.6%-$66.34M-29.8%
-$0.77+2.5%-$0.90-32.4%-$0.95-21.8%-$0.820.0%-$0.79-2.6%
-$0.77+2.5%-$0.90-32.4%-$0.95-21.8%-$0.820.0%-$0.79-2.6%
92.2M+10.4%91.9M+17.0%91.5M+32.3%80.6M+21.0%83.5M+25.3%
92.2M+10.4%91.9M+17.0%91.5M+32.3%80.6M+21.0%83.5M+25.3%
$2.85M-44.6%$3.7M-31.5%$4.71M+0.1%$5.88M+8.2%$5.14M-9.7%
$1.47M+1.1%$1.49M+3.5%$1.48M+3.4%$1.46M+3.3%$1.45M+43.3%
-$580K+82.3%-$876K-143%$591K+45.6%-$3.28M-344%
$341K-9.3%$377K-7.6%$420K-4.1%$551K-17.6%$376K-9.4%
-$71.87M-8.9%-$84.29M-43.1%-$90.42M-57.6%-$79.33M-35.0%-$66.02M-16.8%
-$71.07M-9.3%-$83.49M-43.9%-$89.55M-58.1%-$78.48M-35.2%-$65.02M-16.4%
-$71.07M-9.3%-$83.49M-43.9%-$89.55M-58.1%-$78.48M-35.2%-$65.02M-16.4%
-$71.87M-8.9%-$84.29M-43.1%-$90.42M-57.6%-$79.33M-35.0%-$66.02M-16.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Replimune Group profitable?
Replimune Group is not currently profitable: it reported a net loss of $314.9M over the trailing twelve months.
What is Replimune Group's earnings per share?
Replimune Group's diluted EPS over the trailing twelve months is $-3.44.
Where does Replimune Group's income statement data come from?
Every line is extracted from Replimune Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.